Finnegan is a sponsor of the Tongxieyi webinar series. Finnegan partner Ningling Wang will review the antibody landscape, types of antibody claims, FDA Biosimilars Guidance and best practice recommendations. For more information, or to register, please see Tongxieyi’s website.
antibodies, Food and Drug Administration (FDA), District Court, Enablement (35 USC § 112), inventorship, United States Court of Appeals for the Federal Circuit (CAFC), United States Patent and Trademark Office (USPTO)
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.